Mortality in the TRITON Trial: Update from the FDA Prasugrel Action Package

Victor L. Serebruany

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1356-1357
Number of pages2
JournalThe American Journal of Cardiology
Volume105
Issue number9
DOIs
StatePublished - May 1 2010

Fingerprint

Piperazines
Purinergic P2 Receptors
Drug Approval
Thiophenes
Thrombolytic Therapy
United States Food and Drug Administration
Myocardial Infarction
Mortality
Prasugrel Hydrochloride

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Mortality in the TRITON Trial : Update from the FDA Prasugrel Action Package. / Serebruany, Victor L.

In: The American Journal of Cardiology, Vol. 105, No. 9, 01.05.2010, p. 1356-1357.

Research output: Contribution to journalArticle

@article{dc457a826c3445bea8e471b5a0ef2bc1,
title = "Mortality in the TRITON Trial: Update from the FDA Prasugrel Action Package",
author = "Serebruany, {Victor L.}",
year = "2010",
month = "5",
day = "1",
doi = "10.1016/j.amjcard.2009.12.052",
language = "English (US)",
volume = "105",
pages = "1356--1357",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Mortality in the TRITON Trial

T2 - Update from the FDA Prasugrel Action Package

AU - Serebruany, Victor L.

PY - 2010/5/1

Y1 - 2010/5/1

UR - http://www.scopus.com/inward/record.url?scp=77950917917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950917917&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2009.12.052

DO - 10.1016/j.amjcard.2009.12.052

M3 - Article

C2 - 20403493

AN - SCOPUS:77950917917

VL - 105

SP - 1356

EP - 1357

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 9

ER -